A Clinical Trial to Evaluate the Blood Pressure Lowering Effect of a Candemore Plus Tab Versus Cantabell Tab in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 132 participants.
Also called NCT04521023
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 132 participants
- Registry
-
NCT04521023
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT04521023. Randomized; double masking; primary purpose treatment. Start 2017-09-20 (actual); primary completion 2020-01-28 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Clinical Trial to Evaluate the Blood Pressure Lowering Effect of a Candemore Plus Tab Versus Cantabell Tab in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy
- Condition
- Hypertension
- Intervention (Drug)
- Cantabell Tab
- Intervention (Drug)
- Candemore Plus Tab
- Lead sponsor
- Chong Kun Dang Pharmaceutical
Record details
- Record id
cardio:ct-nct04521023- Content hash
c8e5e852bb1ce616392b190fc8a7c7a89974d3dec4dfbf8d5a71891600a20562